Cita APA (7a ed.)
Yurgelun-Todd, D. A., Renshaw, P. F., Goldsmith, P., Uz, T., & Macek, T. A. (2020). A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects. Psychopharmacology, 237(2), 317-329.
Cita Chicago Style (17a ed.)
Yurgelun-Todd, Deborah A., Perry F. Renshaw, Paul Goldsmith, Tolga Uz, y Thomas A. Macek. "A Randomized, Placebo-controlled, Phase 1 Study to Evaluate the Effects of TAK-063 on Ketamine-induced Changes in FMRI BOLD Signal in Healthy Subjects." Psychopharmacology 237, no. 2 (2020): 317-329.
Cita MLA (9a ed.)
Yurgelun-Todd, Deborah A., et al. "A Randomized, Placebo-controlled, Phase 1 Study to Evaluate the Effects of TAK-063 on Ketamine-induced Changes in FMRI BOLD Signal in Healthy Subjects." Psychopharmacology, vol. 237, no. 2, 2020, pp. 317-329.
Precaución: Estas citas no son 100% exactas.